8-K Announcements
6Material company update
May 5, 2026·SEC
Material company update
Mar 27, 2026·SEC
Material company update
Mar 4, 2026·SEC
Ardent Health Partners, LLC(ARDT)Earnings, Financials & Key Ratios
ARDT•NYSE
$9.73
10.1× P/E·Price updated Jun 27, 2026
AboutArdent Health Partners, LLC owns and operates a network of hospitals and clinics that provides a range of healthcare services in the United States. It operates acute care hospitals, including rehabilitation hospitals and surgical hospitals. The company was founded in 2001 and is based in Brentwood, Tennessee. Ardent Health Partners, LLC is a subsidiary of EGI-AM Investments, L.L.C.Show more
- Revenue$6.32B+6.0%
- EBITDA$481M-12.8%
- Net Income$136M-35.4%
- EPS (Diluted)0.96-39.2%
- Gross Margin97.54%+18.0%
- EBITDA Margin7.61%-17.8%
- Operating Margin5.15%-24.3%
- Net Margin2.15%-39.1%
- ROE8.47%-47.6%
ARDT Price & Volume
Ardent Health Partners, LLC (ARDT) stock price & volume — 10-year historical chart
Loading chart...
Volatile Operational Margins Offset Deleveraging Progress
Investment Thesis • Updated 2026Q1
VerdictNeutral
Growth:Mixed
Profitability:Strained
Financial Position:Adequate
Cash Flow:Mixed
Primary Risk:Medicaid reimbursement policy volatility
"Ardent Health Partners demonstrates a bifurcated profile characterized by significant balance sheet strengthening and persistent operational volatility. While the company has successfully reduced its debt-to-equity ratio from 2.21 in 2023Q4 to 0.70 in 2026Q1, top-line growth remains inconsistent, fluctuating between a 19.3% expansion and a 0.1% contraction. Investors should monitor the company's ability to stabilize cash flow, as the recent $160.1 million working capital outflow in 2026Q1 highlights ongoing challenges in managing clinical labor obligations against reimbursement cycles."
Verdict Logic
while the valuation is attractive at a 6.12x EV/EBITDA multiple, the persistent volatility in free cash flow margins, which dropped to -5.5% in 2026Q1, warrants a cautious approach until operational consistency is proven.
ARDT Growth Metrics
Ardent Health Partners, LLC (ARDT) revenue, earnings & EPS growth — 3, 5 & 10-year CAGR
Revenue CAGR
10 Years-
5 Years16.07%
3 Years7.23%
TTM6.72%
Profit CAGR
10 Years-
5 Years-
3 Years-10.42%
TTM-40.24%
EPS CAGR
10 Years-
5 Years-
3 Years-10.07%
TTM-42.07%
Return on Capital
10 Years8.36%
5 Years7.61%
3 Years7.84%
Last Year7.89%
ARDT Recent Earnings
Ardent Health Partners, LLC (ARDT) EPS & revenue vs analyst estimates — last 4 quarters
●Beat EPS 6/12 qtrs (75%)●Beat Revenue 5/12 qtrs (63%)
Q2 2026Latest
May 5, 2026Metric
Actual
Est
EPS
$0.28+55.6%
$0.18
Rev
$1.6B+1.5%
$1.6B
Q2 2026
Mar 4, 2026Metric
Actual
Est
EPS
$0.32-8.0%
$0.35
Rev
$1.6B-1.6%
$1.6B
Q4 2025
Nov 12, 2025Metric
Actual
Est
EPS
$0.52+22.6%
$0.42
Rev
$1.6B+1.8%
$1.5B
Q3 2025
Aug 5, 2025Metric
Actual
Est
EPS
$0.52+73.3%
$0.30
Rev
$1.6B+0.7%
$1.6B
| Quarter | Date | EPS (Act vs Est) | Revenue (Act vs Est) |
|---|---|---|---|
| Q2 2026Latest | May 5, 2026 | $0.28vs $0.18+55.6% | $1.6Bvs $1.6B+1.5% |
| Q2 2026 | Mar 4, 2026 | $0.32vs $0.35-8.0% | $1.6Bvs $1.6B-1.6% |
| Q4 2025 | Nov 12, 2025 | $0.52vs $0.42+22.6% | $1.6Bvs $1.5B+1.8% |
| Q3 2025 | Aug 5, 2025 | $0.52vs $0.30+73.3% | $1.6Bvs $1.6B+0.7% |
Based on last 12 quarters of dataView full earnings history →
Peers Comparison
Key metrics vs top competitors for Ardent Health Partners, LLC (ARDT)
| Company | Price | Market Cap | P/E Ratio | Rev Growth (1Y) | Net Margin | ROE | Div Yield |
|---|---|---|---|---|---|---|---|
| $9.73 | $1.39B | 10.14 | 6.01% | 2.15% | 8.47% | — | |
| $391.68 | $86.89B | 13.80 | 7.08% | 8.89% | — | — | |
| $189.00 | $16.56B | 12.20 | 3.12% | 7.94% | 19.56% | — | |
| $3.28 | $462.25M | 0.87 | -1.18% | -0.41% | — | — | |
| $145.69 | $9.12B | 6.31 | 9.71% | 8.56% | 20.65% | — | |
| $163.05 | $9.52B | 27.92 | 18.72% | 6.89% | 16.61% | — |
Compare ARDT vs Peers
Ardent Health Partners, LLC (ARDT) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.
ARDT SEC Filings & Documents
Ardent Health Partners, LLC (ARDT) SEC filings — annual & quarterly reports (10-K, 10-Q)
Get notified when ARDT posts new earnings or crosses analyst targets
Free. No account needed. Unsubscribe any time.
ARDT Frequently Asked Questions
Ardent Health Partners, LLC (ARDT) stock FAQ — growth, dividends, profitability & financials explained
Growth & Financials
What is Ardent Health Partners, LLC's revenue?
Ardent Health Partners, LLC (ARDT) reported $6.43B in revenue for fiscal year 2025. This represents a 205% increase from $2.11B in 2016.
How fast is Ardent Health Partners, LLC growing?
Ardent Health Partners, LLC (ARDT) grew revenue by 6.0% over the past year. This is steady growth.
Is ARDT profitable?
Yes, Ardent Health Partners, LLC (ARDT) is profitable, generating $134.3M in net income for fiscal year 2025 (2.1% net margin).
Dividend & Returns
What is ARDT's return on equity?
Ardent Health Partners, LLC (ARDT) has a return on equity (ROE) of 8.5%. This is below average, suggesting room for improvement.
What is Ardent Health Partners, LLC's free cash flow?
Ardent Health Partners, LLC (ARDT) generated $213.8M in free cash flow for fiscal year 2025. Positive FCF indicates the company can fund dividends, buybacks, or reinvestment.